Edwards Lifesciences Corp $ 217.84 -1.58 (-0.72%)
On watch
| Volume: | 601,518 | Avg Vol (1m): | 1,070,047 |
| Market Cap $: | 45.30 Bil | Enterprise Value $: | 45.04 Bil |
| P/E (TTM): | 63.89 | P/B: | 12.92 |
Manual of Stocks™ Web
Financial Strength | 8.2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.4 | ||
| Equity-to-Asset | 0.63 | ||
| Debt-to-Equity | 0.19 | ||
| Debt-to-EBITDA | 0.72 | ||
| Interest Coverage | 2268.4 | ||
| Piotroski F-Score | 7 | ||
| Altman Z-Score | 15.55 | ||
| Beneish M-Score | -1.95 | ||
| WACC vs ROIC | |||
Profitability | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 28.61 | ||
| Net Margin % | 18.29 | ||
| ROE % | 21.82 | ||
| ROA % | 12.94 | ||
| ROC (Joel Greenblatt) % | 56.83 | ||
| 3-Year Revenue Growth Rate | 14.3 | ||
| 3-Year EBITDA Growth Rate | 7.2 | ||
| 3-Year EPS without NRI Growth Rate | 14.5 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 63.89 | ||
| Forward PE Ratio | 36.1 | ||
| PE Ratio without NRI | 63.89 | ||
| Price-to-Owner-Earnings | 85.7 | ||
| PB Ratio | 12.92 | ||
| PS Ratio | 11.65 | ||
| Price-to-Free-Cash-Flow | 65.69 | ||
| Price-to-Operating-Cash-Flow | 47.34 | ||
| EV-to-EBIT | 52.83 | ||
| EV-to-EBITDA | 48.24 | ||
| EV-to-Revenue | 11.35 | ||
| PEG Ratio | 9.6 | ||
| Shiller PE Ratio | 90.43 | ||
| Current Ratio | 3.38 | ||
| Quick Ratio | 2.48 | ||
| Days Inventory | 221.09 | ||
| Days Sales Outstanding | 56.13 | ||
| Days Payable | 55.37 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.9 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 23.32 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 3.82 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 2.41 | ||
| Price-to-Median-PS-Value | 1.93 | ||
| Price-to-Graham-Number | 8.13 | ||
| Earnings Yield (Greenblatt) % | 1.88 | ||
| Forward Rate of Return (Yacktman) % | 2.26 |